 |
Potassium citrate |
|---|---|
| Trade Name | Urocit-K |
| Orphan Indication | 1. Prevention of calcium renal stones in patients with hypocitraturia 2. For avoidance of the complication of calcium stone formation in patients with uric lithiasis. |
| USA Market Approval | USA |
| USA Designation Date | 1984-11-01 00:00:00 |
| Sponsor | University of Texas Health Science Center at Dallas;5323 Harry Hines Blvd;Dallas, Texas, 75235 |
